AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2018
Dec 7, 2018
32552_dirs_2018-12-07_28df2f78-200b-4d14-bd4e-ef73d81cea98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-12-06
Reporting Person: Maxwell John T. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-06 | Common Stock | P | 5000 | $8.87 | Acquired | 153614 | Direct |
Footnotes
F1: Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Board/Management Information
2026
Mar 20
Investor Presentation
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17